Ocala, Fla. -- Lawyers for Wesley Snipes have asked a federal judge to extend his bail while they consider petitioning the U.S. Supreme Court about his prison sentence.
The Orlando Sentinel said the motion was filed Tuesday.
The film star's 2008 conviction and three-year prison sentence for failure to file tax returns and pay federal income taxes were upheld by an appellate court in July. However, he has remained free on bond and his legal team requested a new trial.
A federal judge in Florida last week denied that petition and ordered Snipes to surrender to the U.S. Bureau of Prisons to begin his prison sentence.
The Sentinel said it was not clear where and when Snipes must turn himself in.
The U.S. Supreme Court on Monday will be hearing the case of two police officers who sued their boss after finding out that the department chief invaded their privacy by reading their personal e-mails sent from office equipment.
Washington, November 10 -- The Supreme Court on Monday took up the issue of patent protection and the kind of inventions that qualify for it. The case, Bilksi and Warsaw v. Kappos, involves a method of hedging that has deep rooted implications for the software industry.
New York -- U.S. Supreme Court Justice Antonin Scalia says a New York college professor should not have made him the focus of a student assignment on privacy.
Scalia criticized Fordham University law school Professor Joel Reidenberg for having groups of his students create dossiers on the Supreme Court justice filled with as much personal information they could find, ABC reported Friday.
Washington -- The U.S. Supreme Court says a musician who lost an arm to gangrene has the right to sue pharmaceutical giant Wyeth over drug labeling.
The 6-3 Supreme Court ruling said Diana Winn Levine of Vermont has the right to collect $6.7 million awarded by a jury after the drug maker was found guilty of inadequate labeling of the drug Phenergan, CNN reported Wednesday.
The ruling is seen as a victory for groups seeking to hold the pharmaceutical industry accountable on drug safety.
The anti-nausea drug, which was delivered by a method called IV-push, infected Levine's artery and led to the amputation of her right arm. Wyeth officials said they believed they were prohibited from changing the label without FDA approval.
The court said approval of the drug by federal regulators does not trump consumer safety laws, the report said. "We hold that the jury's verdict against defendant did not conflict with the FDA's labeling requirements for Phenergan because defendant could have warned against IV-push administration without prior FDA approval," the high court said.
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.